Multipotent self-renewing haematopoietic stem cells (HSCs) regenerate the adult blood system after transplantation 1 , which is a curative therapy for numerous diseases including immunodeficiencies and leukaemias 2 . Although substantial effort has been applied to identifying HSC maintenance factors through the characterization of the in vivo bone-marrow HSC microenvironment or niche [3] [4] [5] , stable ex vivo HSC expansion has previously been unattainable 6, 7 . Here we describe the development of a defined, albumin-free culture system that supports the longterm ex vivo expansion of functional mouse HSCs. We used a systematic optimization approach, and found that high levels of thrombopoietin synergize with low levels of stem-cell factor and fibronectin to sustain HSC self-renewal. Serum albumin has long been recognized as a major source of biological contaminants in HSC cultures 8 ; we identify polyvinyl alcohol as a functionally superior replacement for serum albumin that is compatible with good manufacturing practice. These conditions afford between 236-and 899-fold expansions of functional HSCs over 1 month, although analysis of clonally derived cultures suggests that there is considerable heterogeneity in the self-renewal capacity of HSCs ex vivo. Using this system, HSC cultures that are derived from only 50 cells robustly engraft in recipient mice without the normal requirement for toxic pre-conditioning (for example, radiation), which may be relevant for HSC transplantation in humans. These findings therefore have important implications for both basic HSC research and clinical haematology.
. Here we describe the development of a defined, albumin-free culture system that supports the longterm ex vivo expansion of functional mouse HSCs. We used a systematic optimization approach, and found that high levels of thrombopoietin synergize with low levels of stem-cell factor and fibronectin to sustain HSC self-renewal. Serum albumin has long been recognized as a major source of biological contaminants in HSC cultures 8 ; we identify polyvinyl alcohol as a functionally superior replacement for serum albumin that is compatible with good manufacturing practice. These conditions afford between 236-and 899-fold expansions of functional HSCs over 1 month, although analysis of clonally derived cultures suggests that there is considerable heterogeneity in the self-renewal capacity of HSCs ex vivo. Using this system, HSC cultures that are derived from only 50 cells robustly engraft in recipient mice without the normal requirement for toxic pre-conditioning (for example, radiation), which may be relevant for HSC transplantation in humans. These findings therefore have important implications for both basic HSC research and clinical haematology.
To optimize HSC cultures, we initially titrated thrombopoietin (TPO) against stem-cell factor (SCF) in seven-day CD34 bone-marrow competitor cells. The highest peripheral-blood chimerism (about 30%) at 16 weeks was observed with 100 ng ml −1 TPO and 10 ng ml −1 SCF (Fig. 1a) , perhaps owing to the increased c-KIT internalization at higher SCF concentrations causing a loss of sensitivity to SCF (Extended Data Fig. 1c, d) .
These conditions (100 ng ml −1 TPO and 10 ng ml −1 SCF) preferentially induced proliferation from bone-marrow-derived CD150 + CD34 − KSL HSCs rather than bone-marrow-derived CD34 + KSL haematopoietic progenitor cells (Fig. 1b) . We therefore determined whether longer-term ex vivo HSC expansion was possible by attempting one-month-long cultures. Because 50 starting HSCs expanded by approximately 13,000-fold during culture (Fig. 1c) , we transplanted 1 × 10 4 cells per recipient-approximately 1/50th of the culture or about 1 starting HSC equivalent (hereafter termed 'HSCeq'). Using half-medium changes, we only detected short-term reconstitution (Fig. 1d) . However, by performing complete medium changes on the HSC cultures, we achieved cellular expansion similar to These authors contributed equally: Adam C. Wilkinson, Reiko Ishida. *e-mail: nakauchi@stanford.edu; y-sato4@ims.u-tokyo.ac.jp − Lin − bonemarrow cells after a 7-day-long culture in 100 ng ml −1 TPO and 10 ng ml −1 SCF. Statistical significance was calculated using analysis of variance (ANOVA). ***P = 0.004, ****P < 0.0001. Mean ± s.d. of four independent cultures. c, Twenty-eight days of growth of 50 CD34 − KSL HSCs in 100 ng ml −1 TPO and 10 ng ml −1 SCF, and with half or complete medium changes (MC) every 3 days. Mean ± s.d. of four independent cultures. d, Donor peripheral-blood chimerism in recipient mice from 1 × 10 4 HSC-derived cells (about 1 HSCeq), after
Letter reSeArCH half-medium change cultures but also sustained long-term HSC activity from about 1 HSCeq (1 × 10 4 cells) (Fig. 1c, d ). Given the need for complete medium changes during the culture, we hypothesized that HSC plate attachment may help to retain HSCs during medium changes. Of the 5 plate coatings that we tested, fibronectin led to the most improved peripheral-blood chimerism at 16 weeks (Extended Data Fig. 1e ). Although HSC proliferation on fibronectin was similar to that on plastic (Extended Data Fig. 1f ), 1 × 10 4 cells (1.25 HSCeq) from fibronectin cultures at day 28 gave almost 100% peripheral-blood chimerism at 16 weeks (Fig. 1e) . This is consistent with recent suggestions that fibronectin is a bonemarrow niche factor 9 and that fibronectin signalling improves HSC maintenance 10, 11 . Similar to human haematopoietic stem and progenitor cell cultures 12 , several cytokines and chemokines (for example, IL-6 and CCL2, CCL3 and CCL4) were abundant in cultures at day 14 ( Fig. 2a, Extended Data  Fig. 2a ) and suggested mechanisms of haematopoietic progenitor cell contamination; as little as 3 ng ml −1 IL-6 enhanced ex vivo CD34
+ KSL haematopoietic progenitor cell proliferation (Extended Data Fig. 2b ). The secretion profile also suggested the activation of an innate immune response 13 . Consistent with this idea, cytokine secretion was reduced from Tlr4 −/− HSCs or by the addition of dexamethasone (Extended Data Fig. 2c, d ). Conditioned medium also induced loss of HSC activity, which suggests that the differentiation-inducing factors were soluble (Extended Data Fig. 2e ).
Our HSC cultures used yeast-derived recombinant human serum albumin (HSA). We hypothesized that recombinant protein contaminants might be responsible for the inflammatory phenotype 14, 15 and sought replacements for HSA. Serum albumin could have several possible functions in HSC cultures, including as a 'carrier molecule' or as a source of amino acids. As HSCs do not grow in low amino acid media containing albumin 16, 17 , we focused on replacing the carrier-molecule function. Of the 11 chemically synthesized potential replacements that we screened (listed in Methods), only polyvinyl alcohol (PVA) supported HSC survival and growth, and the maintenance of phenotypic haematopoietic stem and progenitor cells (Fig. 2b, Extended Data  Fig. 2f ). In addition, HSCs cultured with PVA outperformed HSCs cultured with HSA in competitive transplantation assays (Fig. 2c) . We also observed significantly lower concentrations of secreted factors in the PVA cultures (Extended Data Fig. 2g ). Senescence-associated gene expression 18, 19 (Trp53, and the Cdkn2a isoforms p16Ink4a and p19Arf) was also reduced in PVA cultures and accumulation of γ-histone 2A.X phosphorylation 20 was not detected (Extended Data Fig. 2h, i) . Consistent with the role of TLR4 in the HSA phenotype, the addition of the TLR4 agonist lipopolysaccharide to PVA cultures caused a similar induction of the Cdkn2a isoforms p16 and p19, as well as the secretion of IL-6 (Extended Data Fig. 2j) .
Although PVA has previously been used for culturing embryonic cell types 21, 22 , its mechanistic role is poorly understood. To investigate the properties of PVA that enable it to act as an albumin replacement, IL-1β  IL-6  IFNα  TNF  CCL2  CCL3  CCL4  CCL7  CXCL2  CXCL10  0   40   80   120   160 200 − KSL HSCs following a 7-day-long culture in HSA-based or PVA-based medium, supplemented with 100 ng ml −1 TPO and 10 ng ml null /SzJ) mice (n = 5 mice per group) following transplantation with 7-day-long cultures derived from 2 × 10 3 CD34 + cells. Statistical significance was calculated using ANOVA. **P = 0.0098.
we compared states of PVA hydrolysis. Our initial screen used 87% hydrolysed PVA (87% PVA), an amphiphilic polymer that contains acetate and alcohol domains. By contrast, more-than-99% hydrolysed PVA (99% PVA) lacks acetate domains. HSCs survived in medium that contained either form of PVA, but proliferation was fivefold-less in 99% PVA cultures (Fig. 2d, Extended Data Fig. 2k ). However, competitive transplantation of 1 × 10 4 cells from 87% PVA and 99% PVA cultures at day 28 demonstrated that both types of PVA supported HSCs ex vivo (Fig. 2e) .
As an inexpensive albumin replacement that is compatible with good manufacturing practice, PVA may also have important implications for the expansion of human HSCs. As proof-of-concept, we confirmed that PVA can replace serum albumin in human umbilical-cord-blood-derived CD34
+ haematopoietic stem and progenitor cell cultures (Extended Data Fig. 2l ). However, human CD34 + CD38 − CD90 + CD49f + HSCs proliferated to a similar extent in both 87% PVA and 99% PVA (Fig. 2f) , which suggests that-unlike in mouse-human HSC proliferation is not sensitive to amphiphilic PVA. Both types of PVA could maintain functional HSC activity ex vivo (Fig. 2g) .
From the results above, we defined the optimal mouse HSC culture conditions as: 100 ng ml −1 TPO, 10 ng ml −1 SCF and 87% PVA on fibronectin (Fig. 3a) . Under these conditions, 50 CD150
HSCs expanded approximately 8,000-fold over 28 days (Fig. 3b) . In limiting dilution assays of cultures at 28 days (transplanted against 2 × 10 5 bone-marrow competitors), only 50 cell aliquots displayed more than 1% multilineage peripheral-blood chimerism at 16 weeks, in 2 out of 3 recipients (Extended Data Fig. 3a, b) . Using extreme limiting dilution analysis 23 , we calculated the HSC frequency as 1:34.3 cells, which is equivalent to 1.2 × 10 4 functional HSCs in the culture at day 28 (Fig. 3c) . This compares to a 1:3.8 frequency of functional HSCs within the freshly isolated CD150 + CD34 − KSL population (on the basis of previous transplantation data 24 ). We therefore estimate that the expansion of functional HSCs is between 236-fold (assuming all 50 starting cells were functional HSCs) and 899-fold (assuming 1:3.8 starting cells (about 13 cells) were functional HSCs).
Secondary transplantation was performed by pooling bone marrow from the primary limiting dilution assay recipients (3 of these recipients survived to 16 weeks): all secondary recipients of 1 × 10 6 bone-marrow cells from 100-cell and 50-cell primary transplants displayed donor peripheral-blood chimerism at 12 weeks (Fig. 3d ). Because these were pooled secondary transplants, we can only conclude that at least 1 in 150 cells at day 28 were serially transplantable long-term HSCs. We therefore estimate that the expansion of serially engraftable HSCs, at a minimum, is between 54-fold (assuming all starting cells were functional HSCs) and 204-fold (assuming only 1:3.8 of starting cells (about 13 cells) were functional HSCs).
Consistent with the high functional activity at day 28, senescence markers were not increased and Trp53 remained unmutated (Extended Data Fig. 3c, d ). The KSL population also remained negative for senescence-associated β-galactosidase (Extended Data Fig. 3e, f) . In addition, engrafting HSCs were karyotypically normal (Extended Data  Fig. 3g ). Ex vivo phenotypic KSL populations remained fairly stable during culture (Fig. 3e, Extended Data Fig. 3h) , and most cells in the Fig. 3i ). HSC cultures could also be continued longer term: by day 57 of culture, the 50 starting HSCs had generated approximately 7.3 × 10 6 cells, while retaining a stable phenotypic KSL population and functional HSC activity (Fig. 3b , e, Extended Data Fig. 3j) .
Although mouse bone-marrow HSCs can be highly enriched on the basis of surface-marker expression, purified CD150 + CD34 − KSL cells exhibit substantial functional heterogeneity in single-cell transplantation assays 24, 25 . Consistent with this, considerable variability in the expansion of single HSCs was observed; some cells generated less than 100 cells, whereas others expanded to approximately 5 × 10 5 cells (although more than 90% generated colonies) (Extended Data  Fig. 4a ). The most proliferative clones generated cell numbers similar to those of cultures from 50 or 500 HSCs (Extended Data Fig. 4a ), which suggests that surface area limited growth. Phenotypic heterogeneity was also observed in clonally derived cultures; some clones retained about 90% KSL (Extended Data Fig. 4b ), whereas others almost exclusively generated c-KIT + SCA1 − Lin − cells. Transplantation of clonal cultures resulted in high-level multipotent activity in 4 out of 14 recipients (Extended Data Fig. 4c ). We also detected robust (approximately 15%) peripheral-blood chimerism when clonally derived cultures were divided and transplanted into 5 recipients, against 5 × 10 5 bonemarrow competitors (for 3 out of 10 single HSC cultures tested) (Fig. 3f, g ). These experiments confirmed bona fide HSC self-renewal ex vivo, but suggested that the self-renewal capacity is unevenly distributed within the phenotypic HSC compartment.
Radiation-based bone-marrow conditioning is normally required to make space for donor HSCs in HSC transplantation. Donor engraftment in nonconditioned recipients is possible but normally not feasible, because very large numbers of HSCs are required for the transplant 26, 27 . By expanding 50 HSCs for 28 days before transplantation, we could achieve long-term donor peripheral-blood and bone-marrow HSC chimerism in nonconditioned immunocompetent mice (Fig. 4a-c) . This approach could also be used to engraft immunodeficient NOD/SCID mice, a model of congenital immunodeficiency; multilineage peripheral-blood chimerism was observed in all recipients with donor lymphoid B and T cells detected in the long term (Extended Data Fig. 5a-c) .
In summary, we have developed an albumin-free ex vivo culture condition that expands functional mouse HSCs (Fig. 4d) , which has the potential for broad applications in HSC research. Although we have been able to isolate HSCs at high purity for over 20 years 1 , stable ex vivo expansion of functional HSCs has not been achievable. Our results suggest that poor optimization of existing culture constituents, combined with medium supplement impurities, have been a major barrier to ex vivo HSC expansion.
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No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to outcome assessment. Mice. C57BL/6-CD45.2 and C57BL/6-CD45.1 (PepboyJ) mice were purchased from Japan SLC, Sankyo-Laboratory Service, Jackson Laboratories (000664, 002014) or bred in-house. For congenic transplantation experiments, 8-12-week-old male mice were used as donors and 8-12-week-old female mice were used as recipients. Tlr2 knockout mice, Tlr4 knockout mice, and NOD/SCID (NOD. Cg-Prkdc scid ) mice were purchased from Jackson Laboratories (004650, 007227 and 001303, respectively). NOG (NOD.Cg-Prkdc scid Il-2rγ null /SzJ) mice were purchased from In Vivo Science. All mice were housed in specific-pathogen-free conditions, with free access to food and water. All animal protocols were approved by the Animal Care and Use Committee of the Institute of Medical Science University of Tokyo, the Animal Care and Use Committee of RIKEN Tsukuba Branch and/or the Administrative Panel on Laboratory Animal Care at Stanford University. Cell collection by fluorescence-activated cell sorting. Mouse bone-marrow cells were isolated from the tibia, femur and pelvis, stained with APC-c-KIT antibody and c-KIT + cells enriched using anti-APC magnetic beads and LS columns (Miltenyi Biotec). The c-KIT-enriched cells were then stained with a lineage antibody cocktail (biotinylated CD4, CD8, CD45R, TER119, LY-6G/LY-6C and CD127), before being stained with anti-CD34, anti-c-KIT, anti-SCA1 and streptavidin-APC/eFluor 780 (as detailed in Extended Data Table 1 ) for 90 min. Where indicated, cells were also stained with anti-CD150. Cell populations were then purified using a FACS AriaII (BD) by direct sorting into wells containing media using propidium iodide as a dead stain (Extended Data Fig. 1b) . Serum-albumin-based mouse-cell cultures. Serum-albumin-based cultures were performed using F12 medium (Life Technologies), 1% insulin-transferrinselenium-ethanolamine (ITSX; Life Technologies), 1% penicillin/streptomycin/ glutamine (P/S/G; Life Technologies), 10 mM HEPES (Life Technologies), 0.1% recombinant HSA (Albumin Biosciences), at 37 °C with 5% CO 2 . Cultures were supplemented with recombinant mouse SCF and recombinant mouse TPO (Peprotech), as indicated. All long-term cultures used 10 ng ml −1 SCF and 100 ng ml
TPO, with medium changes made every 3 days after the first 5 days, by manually removing conditioned medium by pipetting and replacing fresh medium as indicated. In a 96-well plate, wells containing 200 μl of medium, this involved gentle removal of 190-200 μl of the conditioned medium using a pipette to avoid disturbing cells that were lightly adherent to the well bottom, and then gently pipetting in 200 μl of pre-warmed and freshly prepared medium down the side of the well to minimize disturbing the cell layer. Any cells removed from the well in the conditioned medium were discarded. Long-term cultures were performed using flat-bottomed plates, tissue-culture-treated and/or coated with fibronectin (Corning; 354409), collagen 1 (Corning; 354407), collagen 4 (Corning; 354429), gelatin (Sigma; G2500) or laminin 511 (iMatrix; 892018). Where indicated, various concentrations of recombinant mouse IL-6 (Peprotech) were added to cultures. Serum-albumin-free mouse-cell cultures. HSCs were cultured in medium composed of F12 medium, 1% ITSX, 10 mM HEPES, 1% P/S/G, 100 ng ml −1 mouse TPO, 10 ng ml −1 mouse SCF and 0.1% of one the following chemicals (all from Sigma): hydroxypropyl cellulose (HPC; 435007), low-viscosity carboxymethylcellulose sodium salt (CMC-LV; C5678), medium-viscosity carboxymethylcellulose sodium salt (CMC-MV; 21902), α-cyclodextrin (α-CD; C4642), β-cyclodextrin (β-CD; C4767), γ-cyclodextrin (γ-CD; C4930), 2-hydroxypropyl-β-l-cyclodextrin (HBC; H107), 2-hydroxypropyl-γ-cyclodextrin (HGC; H125), methyl-β-cyclodextrin (MBC; C4555), poloxamer 188 (Polox188; P5556), PVA (P8136, 363081 or 363146) or polyethylene glycol (PEG), at 37 °C with 5% CO 2 . For long-term cultures in PVAbased cultures, complete medium changes were made every 2-3 days after the first 5-6 days, as described above for albumin-based cultures. Long-term cultures were split 1:3 at ~90% confluency. Where indicated, lipopolysaccharide (Sigma L2762) or IL-6 (Peprotech) were added to cultures. Analysis of cultured cells. Following ex vivo culture, cells were counted (using a haemocytometer, a CYTORECON cytometer or a Nucleocounter NC-3000). For flow cytometric analysis, cells were stained with a lineage cocktail (biotinylated CD4, CD8, CD45R, TER119, LY-6G/LY-6C and CD127) and then with antibodies detailed in Extended Data Table 1 for 30-90 min. Following a wash step, flow cytometric analysis was performed using a FACS AriaII (BD), LSRFortessa (BD) or FACS Canto (BD) using propidium iodide as a dead stain. Competitive transplantation assay. Cultured HSCs from C57BL/6-CD45.1 mice were transplanted alongside 1 × 10 6 whole bone-marrow competitor cells from C57BL/6-CD45.1/CD45.2 (F1) mice into C57BL/6-CD45.2 mice, following irradiation at a lethal dose (9.5 Gy). Donor chimerism was tracked by collecting peripheral-blood cells and staining with anti-CD45.1, anti-CD45.2, anti-CD11b, anti-LY-6G/LY-6C, anti-CD45R, anti-CD4 and anti-CD8 antibodies (detailed in Extended Data Table 1 ) for 30 min. Following a wash step, cells were analysed by flow cytometry (as above) using propidium iodide as a dead stain. Secondary bone-marrow transplantation assays were performed by transferring 1 × 10 6 bone-marrow cells from the primary recipient mice into lethally irradiated C57BL/6-CD45.2 mice, with donor chimerism analysed as above. Limiting dilution assays. For limiting dilution assays, set numbers of cultured C57BL/6-CD45.1 cells were aliquoted by fluorescence-activated cell sorting (FACS) after culture, and transplanted into lethally irradiated C57BL/6-CD45.2 recipient mice, together with 2 × 10 5 F1 bone-marrow competitor cells. Donor chimerism was analysed as above. Limiting dilution analysis was performed using ELDA software 23 , based on a 1% peripheral-blood multilineage chimerism (at least 0.2% myeloid donor chimerism) as the threshold for positive engraftment. To calculate fresh HSC frequency, the same criteria were applied to a total of 138 transplantation assays from freshly isolated CD150 + CD34 − KSL cells that were previously published 24, 25 . Where indicated, secondary transplantation assays were performed as described above. Nonconditioned transplantation assays. CD150 + CD34 − KSL cells were purified from C57BL/6-CD45.1 or C57BL/6-CD45.2 mice and expanded, as described above. Freshly isolated or expanded bulk-cell cultures were then transplanted into non-irradiated C57BL/6-CD45.1/CD45.2 recipient mice or NOD/SCID (CD45.1) recipient mice, split into three doses over consecutive days. Cytokine immunoassays. Conditioned medium was collected at day 7 (before any medium change) or day 14 (following a medium change at day 10), or as indicated in the figure legends. Mouse 39-plex kits (eBiosciences) were used according to the manufacturer's recommendations, with modifications described below. In brief, beads were added to a 96-well plate and washed in a Biotek ELx405 washer. Samples were added to the plate containing the mixed antibody-linked beads and incubated at room temperature for 1 hour, followed by overnight incubation at 4 °C with shaking. Cold and room-temperature incubation steps were performed on an orbital shaker at 500-600 r.p.m. Following the overnight incubation, plates were washed in a Biotek ELx405 washer and then biotinylated detection antibody was added for one hour at room temperature with shaking. The plate was washed as above, and streptavidin-PE was added. After incubation for 30 min at room temperature, the wash was performed and reading buffer was added to the wells. Plates were read using a Luminex Flex3D instrument with a lower bound of 50 beads per sample per cytokine. Custom control beads (Assay CHEX) by Radix Biosolutions were added to all wells. Human cell cultures and xenograft assays. Human umbilical-cord-bloodderived CD34
+ cells (purchased from Lonza or Stem Cell Technologies) or FACSpurified CD34
CD49f
+ cells (following staining with APC-CD34 (Biolegend, 560940), PE-CD38 (BD, 347687), FITC-CD90 (Biolegend, 328113) and APC/Cy7-CD49f (Biolegend, 313611)) were cultured in IMDM (Life Technologies) containing 0.1% HSA or 0.1% PVA (Sigma P8136, 363081, or 363146), supplemented with 1% ITSX, 1% P/S/G and 10 mM HEPES. For proliferation assays, 50 cells were seeded per well and supplemented with 10 ng ml −1 human SCF and 100 ng ml −1 human TPO (Peprotech). During the cultures, medium was refreshed every three days and counted at day seven. For xenograft assays, 2 × 10 3 cells were expanded for 7 days before being injected intravenously into sub-lethally irradiated (1.5 Gy) NOG mice. Human cell chimerism in the peripheral blood was calculated at 16 weeks post-transplantation, using PE/Cy7-CD45.1 (Biolegend; 110730) and V450-human CD45 antibodies (BD; 560367). Senescence analysis. Total RNA of KSL cells was extracted using the RNeasy Mini Kit (Qiagen) and reverse-transcribed using SuperScript III First-Strand Synthesis System and Oligo (dT) primers (Invitrogen). Quantitative PCR was performed on a Thermal Cycler Dice Real Time System (Takara) using SsoAdvancedTM Universal SYBR Green Supermix and the following primer sets: p16Ink4a (GAACTCTTTCGGTCGTACCC and CGAATCTGCACCGTA GTTGA), p19Arf (GGGTTTTCTTGGTGAAGTTCG and TTGCCCATCATCA TCACCT) and Trp53 (CAGTCTACTTCCCGCCATAA and GTCTCAGCCCTGA AGTCATAAG). The reaction conditions were 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s, 60 °C for 30 s and 72 °C for 20 s. Gene expression of genes was normalized relative to Gapdh expression (using primer set: CGACTTCAACAG CAACTCCCACTCTTCC and TGGGTGGTCCAGGGTTTCTTACTCCTT). Senescence β-galactosidase staining (Cell Signaling, Kit 9860S) was performed according to the manufacturer's instructions, following cell attachment to poly-l-lysine-coated plates. For Sanger sequencing, Trp53 cDNA was PCR-amplified (using primer set: CATCCTGGCTGTAGGTAGCG ACCCTATGAGGGCCCAAGAT) and sequenced using nested sequencing primers: AAAAGTCTGCCTGTCTTCCAG; TGATGGCCTGGCTCCTCC; CACGTACTCTCCTCCCCTCA; and CTTCTGTACGGCGGTCTCTC. Sanger sequencing was outsourced to FASMAC, and visualized and aligned using SnapGene software. Phospho-protein fluorescence immunostaining. Fluorescence immunostaining was performed by attaching, fixing and staining cells on poly-l-lysine-coated glass slides (Matsunami Glass), with imaging and quantification performed with a Cellomics ArrayScan VTI HCS Reader (Thermo Scientific), using previously described methods 20, 28 . Karyotyping analysis. Karyotyping was performed on CD45.1 + bonemarrow cells, FACS-purified from primary recipients of 28-day-long PVA-cultured HSCs at 16 weeks post-transplantation, and performed by Nihon Gene Research Laboratories. Statistical analysis. One-way and two-way ANOVA tests and unpaired two-tailed t-tests were performed as indicated in the figures, using Prism 7 software. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Letter reSeArCH 
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Extended Data Fig. 1 | Optimizing conditions for long-term HSC culture. a, Schematic of the standard HSC culture assay. Bone-marrow CD34 − KSL HSCs of C57BL/6-CD45.1 mice were sorted (50 cells per well) into U-bottomed 96-well plate wells (b for sorting scheme). HSC growth can be observed during culture by counting or flow cytometry, with medium changes made every three days (after an initial seven days in culture). After 7-28 days, functional HSC activity was determined using competitive transplantation into irradiated C57BL/6-CD45.2 mice, against 1 × 10 6 bone-marrow competitor cells from C57BL/6-CD45.1/ CD45.2 (F1) mice. Donor chimerism within peripheral-blood myeloid, T cell and B cell lineages was determined after 4-16 weeks, or longer. Where indicated, secondary transplantation assays were performed by transplanting 1 × 10 6 bone-marrow cells from primary recipients into irradiated C57BL/6-CD45.2 mice. b, FACS gating strategy for sorting CD34
− KSL cells (gates 1-7) and CD150 + CD34 − KSL cells (gates 1 Medium changes performed at day 7 and day 10. Mean of four independent cultures with fold change relative to unconditioned medium. Error bars denote s.d. b, Mean expansion of 50 CD34 + KSL haematopoietic progenitor cells at day 7, in 100 ng ml −1 TPO and 10 ng ml −1 SCF with or without addition of 0.3 ng ml −1 to 10 ng ml −1 mouse IL-6 (n = 4 cell cultures). c, Heat map displaying the MFI fold change from cytokine immunoassays using conditioned medium from HSC cultures at day 14. CD34
− KSL HSCs were isolated from C57BL/6 wild-type (WT), Tlr2 knockout (TLR2-KO) or Tlr4 knockout (TLR4-KO) mice, and cultured in HSA-based cultures. Dexamethasone (+Dex) at 50 nM was added, where indicated. Mean of four independent cultures with fold change relative to unconditioned medium. d, Concentration of IL-6 observed in HSA-based cultures at day 14 of wild-type HSCs (n = 8 cell cultures), Tlr2 knockout HSCs (n = 8 cell cultures), Tlr4 knockout HSCs (n = 6 cell cultures), or wild-type HSCs + dexamethasone (n = 8 cell cultures). Error bars denote s.d. e, Mean donor peripheral-blood chimerism at week 12, from HSCs cultured for 7 days, in fresh medium (n = 7 mice) or in medium composed of 50% medium collected from a 12-day-long HSC culture and 50% fresh medium (termed 'conditioned media' , n = 7 mice). Competitive transplantation against 1 × 10 6 bone-marrow competitors. f, Example flow cytometry plots displaying c-KIT and SCA1 expression on the Lin − progeny (left), and CD150 and CD48 expression in the KSL population (right) after a PVA-based HSC culture for seven days. Representative of four independent cultures. g, Concentration of various cytokines in conditioned medium at day 14, from HSA-or PVA-based CD34 − KSL HSC cultures. Mean of eight independent cultures. Error bars denote s.d. Statistical significance was calculated using t-tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. h, Relative expression of p16Ink4a, p19Arf and Trp53 in KSL cells collected from cultures at day 14 (HSA-based cultures with half-medium changes, HSA-based cultures with complete medium changes and PVA-based cultures with complete medium changes), relative to expression in freshly isolated KSL cells. + CD34 − KSL cells from C57BL/6-CD45.2 mice were expanded for 28 days before being transplanted into nonconditioned immunodeficient NOD/SCID recipient mice. b, Donor peripheral-blood chimerism at week 4, from 100 fresh HSCs (n = 5 mice) or a 28-day-long HSC culture derived from 100 HSCs (n = 5 mice), transplanted as described in a. Each column represents an individual mouse. c, Example flow cytometry plots displaying T cell (CD4 and CD8) and B cell (CD45R, also known as B220) peripheralblood lineages within nonconditioned NOD/SCID mice at 16 weeks after transplantation (representative of 5 mice), as described in a. 
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